Gastrointestinal hypomotility: An under-recognised life-threatening adverse effect of clozapine

Forensic Science International

Volumn 206, Issue 1-3, 2011, Pages

  Flanagan, R J ^a   Ball, R Y ^b  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Clozapine: gastrointestinal hypomotility; Clozapine: interpretation of post mortem toxicology; Clozapine: paralytic ileus

Indexed keywords

CLOZAPINE; NORCLOZAPINE;

ADULT; ARTICLE; ASPIRATION; AUTOPSY; BLOOD STAIN; CASE REPORT; CAUSE OF DEATH; COLON DILATATION; CONSTIPATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG FATALITY; FEMUR; HUMAN; HUMAN TISSUE; JEJUNUM; MALE; MUCUS; PRIORITY JOURNAL; SMALL INTESTINE;

EID: 79952454243     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.07.021     Document Type: Article

References (47)

1. Flanagan R.J., Dunk L. Haematological toxicity of drugs used in psychiatry. Hum. Psychopharmacol. 2008, 23(S1):S27-S41.
2. Trenton A., Currier G., Zwemer F. Fatalities associated with therapeutic use and overdose of atypical antipsychotics. CNS Drugs 2003, 17:307-324.
3. Flanagan R.J. Fatal toxicity of drugs used in psychiatry. Hum. Psychopharmacol. 2008, 23(S1):S43-S51.
4. Flanagan R.J., Spencer E.P., Morgan P.E., Barnes T.R.E., Dunk L. Suspected clozapine poisoning in the UK/Eire, 1992-2003. Forensic Sci. Int. 2005, 155:91-99.
5. Couchman L., Morgan P.E., Spencer E.P., Flanagan R.J. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a Therapeutic Drug Monitoring service, 1993-2007. Ther. Drug Monit. 2010, 32:438-447.
6. Alexopoulos G.S., Streim J., Carpenter D., Docherty J.P. Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients, Using antipsychotic agents in older patients. J. Clin. Psychiatr. 2004, 65(Suppl. 2):5-99.
7. Holzer P., Ahmedzai S.H., Niederle N., Leyendecker P., Hopp M., Bosse B., Spohr I., Reimer K. Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management. J. Opioid Manag. 2009, 5:145-151.
8. Baker D.E. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction. Rev. Gastroenterol. Disord. 2009, 9:E84-E93.
9. Onali P., Olianas M.C. N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors. Neuropsychopharmacology 2007, 32:773-785.
10. R.J. Flanagan, Interpretation of post-mortem toxicology: more complicated than it might seem, Adverse Drug React. Bull. Part 1, 249 (2008) 955-958; Part 2, 250 (2008) 959-962.
11. Flanagan R.J. Side-effects of clozapine and some other psychoactive drugs. Curr. Drug. Saf. 2008, 3:115-122.
12. Karppi J., Akerman K.K., Parviainen M. Suitability of collection tubes with separator gels for collecting and storing blood samples for therapeutic drug monitoring (TDM). Clin. Chem. Lab. Med. 2000, 38:313-320.
13. Flanagan R.J., Amin A., Seinen W. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa). Forensic Sci. Int. 2003, 132:9-17.
14. Centorrino F., Baldessarini R.J., Kando J.C., Frankenburg F.R., Volpicelli S.A., Flood J.G. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients. J. Clin. Psychopharmacol. 1994, 14:119-125.
15. Bever K.A., Perry P.J. Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapy. Am. J. Health Syst. Pharm. 1998, 155:1003-1016.
16. Chengappa K.N., Pollock B.G., Parepally H., Levine J., Kirshner M.A., Brar J.S., Zoretich R.A. Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J. Clin. Psychopharmacol. 2000, 20:311-316.
17. Kelly D.L., Richardson C.M., Yu Y., Conley R.R. Plasma concentrations of high-dose olanzapine in a double-blind crossover study. Hum. Psychopharmacol. 2006, 21:393-398.
18. Peyrière H., Roux C., Ferard C., Deleau N., Kreft-Jais C., Hillaire-Buys D., Boulenger J.P., Blayac J.P. French network of the pharmacovigilance centers, antipsychotics-induced ischaemic colitis and gastrointestinal necrosis: a review of the French pharmacovigilance database. Pharmacoepidemiol. Drug Saf. 2009, 18:948-955.
19. Palmer S.E., McLean R.M., Ellis P.M., Harrison-Woolrych M. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases. J. Clin. Psychiatr. 2008, 69:759-768.
20. Hibbard K.R., Propst A., Frank D.E., Wyse J. Fatalities associated with clozapine-related constipation and bowel obstruction: a literature review and two case reports. Psychosomatics 2009, 50:416-419.
21. Robb A.S., Lee R.H., Cooper E.B., Siedel J.V., Nusrat N. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents. J. Child Adolesc. Psychopharmacol. 2008, 18:99-107.
22. Hayes G., Gibler B. Clozapine-induced constipation. Am. J. Psychiatr. 1995, 152:298.
23. Théret L., Germain M.L., Burde A. Current aspects of the use of clozapine in the Châlons-sur-Marne Psychiatric Hospital: intestinal occlusion with clozapine. Ann. Med. Psychol. (Paris) 1995, 153:474-477.
24. Drew L., Herdson P. Clozapine and constipation: a serious issue. Aust. N. Z. J. Psychiatr. 1997, 31:149-150.
25. Shammi C.M., Remington G. Clozapine-induced necrotizing colitis. J. Clin. Psychopharmacol. 1997, 17:230-232.
26. Ferslew K.E., Hagardorn A.N., Harlan G.C., McCormick W.F. A fatal drug interaction between clozapine and fluoxetine. J. Forensic Sci. 1998, 43:1082-1085.
27. Levin T.T., Barrett J., Mendelowitz A. Death from clozapine-induced constipation: case report and literature review. Psychosomatics 2002, 43:71-73.
28. Khaldi S., Gourevitch R., Matmar M., Llory A., Olie J.P., Chauvelot-Moachon L. Necrotizing enterocolitis after antipsychotic treatment involving clozapine and review of severe digestive complications - a case report. Pharmacopsychiatry 2005, 38:220-221.
29. Townsend G., Curtis D. Case report: rapidly fatal bowel ischaemia on clozapine treatment. BMC Psychiatr. 2006, 6:43.
30. Leong Q.M., Wong K.S., Koh D.C. Necrotising colitis related to clozapine? A rare but life threatening side effect. World J. Emerg. Surg. 2007, 2:21.
31. Pelizza L., De Luca P., La Pesa M., Borella D. Clozapine-induced intestinal occlusion: a serious side effect. Acta Biomed. 2007, 78:144-148.
32. Pelizza L., Melegari M. Clozapine-induced microscopic colitis: a case report and review of the literature. J. Clin. Psychopharmacol. 2007, 27:571-574.
33. Rondla S., Crane S. A case of clozapine-induced paralytic ileus. Emerg. Med. J. 2007, 24:e12.
34. Rousseau A., Charbonneau M. Severe fecal impaction under clozapine, resulting in death. J. Assn. Med. Psychiatr. Quebec 2007, 11:16-18.
35. Rege S., Lafferty T. Life-threatening constipation associated with clozapine. Australas. Psychiatr. 2008, 16:216-219.
36. de Bruin G.J., Bac D.J., van Puijenbroek E.P., van der Klooster J.M. Ogilvie Syndrome induced by clozapine. Ned. Tijdschr. Geneeskd. 2009, 153:B437.
37. McKinnon N.D., Azad A., Waters B.M., Joshi K.G. Clozapine-induced bowel infarction: a case report. Psychiatry (Edgmont) 2009, 6:30-35.
38. Wehmeier P.M., Heiser P., Remschmidt H. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. J. Clin. Pharm. Ther. 2005, 30:91-96.
39. Rostami-Hodjegan A., Amin A.M., Spencer E.P., Lennard M.S., Tucker G.T., Flanagan R.J. Influence of dose, cigarette smoking, age, sex and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients. J. Clin. Psychopharmacol. 2004, 24:70-78.
40. Saunders M.D., Kimmey M.B. Systematic review: acute colonic pseudo-obstruction. Aliment. Pharmacol. Ther. 2005, 22:917-925.
41. Morales M.A., Hernández D., Bustamante S., Bachiller I., Rojas A. Is senna laxative use associated to cathartic colon, genotoxicity, or carcinogenicity?. J. Toxicol. 2009, Epub Sep 10.
42. Wald A. Is chronic use of stimulant laxatives harmful to the colon?. J. Clin. Gastroenterol. 2003, 36:386-389.
43. Friedberg J.W., Frankenburg F.R., Burk J., Johnson W. Clozapine-caused eosinophilic colitis. Ann. Clin. Psychiatr. 1995, 7:97-98.
44. Karmacharya R., Mino M., Pirl W.F. Clozapine-induced eosinophilic colitis. Am. J. Psychiatr. 2005, 162:1386-1387.
45. Sim K., Yong T.W., Liew E., Choon C.H. Clozapine-associated pseudomembranous colitis: a case report and review of the literature. J. Clin. Psychopharmacol. 2006, 26:89.
46. Beck D.A., Miller D.D. Clozapine-associated neutropenic enterocolitis. Ann. Clin. Psychiatr. 1994, 6:185-188.
47. Verbeeck W.J., Berk M. Clozapine associated neutropenia and cytomegalovirus colitis. Pharmacopsychiatry 1998, 31:236-237.